Pilibhit to get 200-acre bio-pharma park
The story in brief
UPSIDA is developing a 951.79-acre industrial area in Pilibhit’s Amaria tehsil, with 200 acres dedicated to a bio-pharma park focused on vaccines, insulin, gene therapies, and monoclonal antibodies. The project aims to expand industrial development beyond major cities and create investment and employment opportunities in Pilibhit and smaller districts. Plans include a biotechnology institute, skill development facilities, and an incubation centre to train local youth and support startups.